CervoMed EPS
The Earnings per Share (EPS) of CervoMed (CRVO) as of Oct 19, 2026 is -2.91 USD. In the previous year, Earnings per Share (EPS) was -1.87 USD — a change of 55.70% (lower).
Get this data via API
Financial Data API
EPS
-2.91USD
YoY
55.70%
Last updated:
The CervoMed EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| est | 5.51USD | -549.32% |
| est | -1.23USD | +70.27% |
| est | -0.72USD | -43.01% |
| est | -1.26USD | -14.25% |
| est | -1.48USD | -33.02% |
| est | -2.20USD | -24.44% |
| -2.91USD | +55.70% | |
| -1.87USD | +389.10% | |
| -0.38USD | -96.66% | |
| -11.46USD | -35.35% | |
| -17.73USD | +6.69% | |
| -16.62USD | -37.12% | |
| -26.43USD | -93.65% | |
| -416.55USD | +299.77% | |
| -104.20USD | -94.74% | |
| -1,982.09USD | -49.85% | |
| -3,952.35USD | -53.19% | |
| -8,442.94USD | +71.33% | |
| -4,928.00USD | -92.83% | |
| -68,690.00USD | -69.65% | |
| -226,360.00USD | +169.16% | |
| -84,100.00USD | +147.28% | |
| -34,010.00USD | +62.49% | |
| -20,930.00USD | +2,490.74% | |
| -807.88USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
CervoMed Stock analysis
Frequently Asked Questions about CervoMed stock
Earnings per Share (EPS) of CervoMed is -2.91 USD in 2025.
Earnings per Share (EPS) of CervoMed changed from -1.87 USD to -2.91 USD, representing a 55.70% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) CervoMed since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — CervoMed
All Key Metrics — CervoMed
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth